Related Experiment Video
Updated: Jul 14, 2026
12:04
Intra-Operative Behavioral Tasks in Awake Humans Undergoing Deep Brain Stimulation Surgery
Published on: January 6, 2011
Thirty days complication rate following surgery performed for deep-brain-stimulation
Jürgen Voges1, Rüdiger Hilker1, Kai Bötzel2
1Departments of Neurology and Stereotactic and Functional Neurology, Albertus-Magnus University, Köln, Germany.
Summary
Serious adverse events (SAEs) following Deep-Brain-Stimulation surgery are rare, with a 1% permanent morbidity rate. Pneumonia and intracranial hemorrhage were the most common SAEs, with higher risks in older Parkinson
Area of Science:
- Neurosurgery
- Neurology
- Medical Device Technology
Background:
- Stereotactic surgery for Deep-Brain-Stimulation (DBS) is a critical neurosurgical procedure.
- Understanding the safety profile of DBS is essential for patient care and procedural refinement.
- Retrospective analysis of serious adverse events (SAEs) provides valuable insights into surgical risks.
Purpose of the Study:
- To evaluate the incidence and types of serious adverse events (SAEs) within 30 days post-stereotactic surgery for DBS.
- To identify risk factors associated with SAEs in DBS patients.
- To compare complication rates across different stereotactic centers.
Main Methods:
- Retrospective data collection from 1,183 patients undergoing stereotactic DBS surgery across five German centers.
- Systematic recording of all serious adverse events (SAEs) occurring within the first 30 postoperative days.
- Analysis of mortality, permanent surgical morbidity, and specific SAEs including intracranial hemorrhage and pneumonia.
Main Results:
- The overall mortality rate was 0.4%, with causes including pneumonia and pulmonary embolism.
- Permanent surgical morbidity occurred in 1% of patients.
- The most frequent SAEs were intracranial hemorrhage (2.2%) and pneumonia (0.6%). Skin infections occurred in 0.4% of patients.
- Secondary AEs like pneumonia were more common in older patients and those treated for Parkinson's disease (PD).
Conclusions:
- Stereotactic DBS surgery demonstrates a low rate of serious adverse events and permanent morbidity.
- Intracranial hemorrhage and pneumonia are the primary SAEs requiring attention.
- Risk stratification for older patients and those with Parkinson's disease is recommended to mitigate secondary complications.
